Investors & Media

---

Score Pharma Inc., a biopharmaceutical company pioneering next-generation therapeutic antibody platforms located on the HudsonAlpha Institute for Biotechnology’s Huntsville campus and in strategic partnership with Southern Research in Birmingham, was recently selected as a finalist in the title round pitch competition at ConvergeSouth 2025 and participated as an exhibitor at the event held in Winston-Salem, N.C.(See DOWNLOADS at bottom of page for PDF copy)

Score Pharma CEO said the connection to Station 41 is instrumental in providing access to industry exposure, connections and additional funding. (See DOWNLOADS at bottom of page for PDF copy)

Southern Research has awarded more than $2.7 million in funds to eight biotech companies (including Score Pharma) through a fund established as a result of the  Innovate Alabama Tax Credits.